With an estimated $1.5 billion in potential bonus payments at stake, radiologists should study and respond to recent federal regulations related to meaningful use of complete certified ambulatory electronic health records and their equivalents, say authors of a study in the September issue of the Journal of the American College of Radiology.
With an estimated $1.5 billion in potential bonus payments at stake, radiologists should study and respond to recent federal regulations related to meaningful use of complete certified ambulatory electronic health records and their equivalents, said authors of a study in the September issue of the Journal of the American College of Radiology.
Meaningful use is a hot topic thanks to major incentives for providers who “meaningfully use” certified EHR systems, as well as the looming penalties for those who don’t.
According to meaningful-use experts, many radiologists mistakenly believe they were left out of the meaningful use rewards or that compliance is technically impractical. However, “with diligent preparation, including the adoption of new technology and workflows, the vast majority of radiologists can qualify before October 2012 to capture the full available rewards and avoid later penalties,” said Murray A. Reicher, MD, FACR, co-author of the article and chairman of DR Systems, Inc.
Reicher recommended radiologists get to know the technology and clinical objectives. He also said radiologists should become active participants in their hospital information systems planning process.
“The regulations do not make it easy for radiologists and other specialists to qualify, but they will need to comply nevertheless, using existing and potentially emerging technologies,” Reicher said, adding that the required integration with EHR systems stands to improve patient care.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.